BRIEF-Armo Biosciences Enrolls Patient In The Cypress 2 Trial Evaluating AM0010
Reuters Staff
1 Min Read
March 29 (Reuters) - Armo Biosciences Inc:
* ARMO BIOSCIENCES ENROLLS FIRST PATIENT IN THE CYPRESS 2 TRIAL EVALUATING AM0010 IN NON-SMALL CELL LUNG CANCER Source text for Eikon: Further company coverage: